Abstract:The antibiotic lincomycin binds to the 23S ribosomal RNA peptidyl transferase loop region to inhibit protein synthesis. However, lincomycin can also stimulate the growth and secondary metabolism of actinomycetes in a concentration-dependent manner. In Streptomyces coelicolor A3(2), lincomycin stimulates the production of the blue-pigmented antibiotic actinorhodin at concentrations below the minimum inhibitory concentration. To better understand the molecular mechanism underlying these concentration-dependent positive effects, this study investigated how the target molecule, the ribosome, undergoes dynamic changes in the presence of lincomycin and explored the ribosome-related factors involved. Lincomycin, at a concentration that stimulates actinorhodin production of S. coelicolor A3(2), could restore temporarily arrested ribosome function by utilizing ribosome-related proteins and translation factors, presumably under the control of the transcription factor WblC protein that confers intrinsic resistance to multiple translation-inhibiting antibiotics, to eventually produce stable and active ribosomes even during the late growth phase. This qualitatively and quantitatively positive ribosome alteration can be advantageous for producing actinorhodin biosynthetic enzymes. A series of gene expression and biochemical analyses revealed that lincomycin at the concentration that induces ribosomal stabilization in S. coelicolor A3(2) could influence the localization of the 20S proteasome-related proteins, resulting in reduced proteasome activity. These findings suggest that the functional analysis of 20S proteasome represents a potential pivotal challenge for understanding the molecular mechanism of ribosome stabilization induced by lincomycin. Therefore, as lincomycin can dynamically alter its target molecule, the ribosome, we discuss the future issues and prospects for an increased understanding of the concentration-dependent properties of antibiotics. IMPORTANCE Antibiotics were originally defined as chemical compounds produced by a microbe that inhibits the growth of other microbes. However, an unexplained effect of this is that a low concentration of antibiotics, such as those below the minimum inhibitory concentration, can positively affect microbial growth and metabolism. The secondary metabolic activation of streptomycetes in the presence of the translation-inhibiting antibiotic lincomycin illustrates the concentration-dependent positive effect of the antibiotic. The significance of this study is that the phenomenological interpretation of the molecular mechanism of the concentration-dependent positive effect of lincomycin in Streptomyces coelicolor A3(2) has provided novel insight into the possible role of antibiotics in making their target molecules stable and active with the assistance of various related factors that benefit their function. Further exploration of this idea would lead to an essential understanding of antibiotics, including why actinomycetes make them and their role in nature.

Biotinylation as a tool to enhance the uptake of small molecules in Gram-negative bacteria

Site-specific incorporation of photo-cross-linker and bioorthogonal amino acids into enteric bacterial pathogens.

Genetically Encoded Biotin Analogues: Incorporation and Application in Bacterial and Mammalian Cells

TurboID-mediated surface protein biotinylation to inhibit the growth of Staphylococcus aureus

Deciphering structural variation upon biotinylation of biotin carboxyl carrier protein domain in Streptococcus pneumoniae

Inhibition of efflux pumps aids small-molecule probe-based fluorescence labeling and imaging in the Gram-negative bacterium Escherichia coli

Antibiotic Uptake Across Gram-Negative Outer Membranes: Better Predictions Towards Better Antibiotics

Development of a bioorthogonal fluorescence-based assay for assessing drug uptake and delivery in bacteria

Control of TurboID-dependent biotinylation intensity in proximity ligation screens

Crystal Structure and Acetylation of BioQ Suggests a Novel Regulatory Switch for Biotin Biosynthesis in Mycobacterium Smegmatis

Multi-level Metabolic Engineering of Pseudomonas Mutabilis ATCC31014 for Efficient Production of Biotin.

Engineering a heterologous synthetic pathway in Escherichia coli for efficient production of biotin

Investigating Penetration and Antimicrobial Activity of Vector-Bicycle Conjugates

Selective treatment of intracellular bacterial infections using host cell-targeted bioorthogonal nanozymes

Simulation and Assay of Protein Biotinylation with Electrochemical Technique.

A scalable metabolite supplementation strategy against antibiotic resistant pathogen Chromobacterium violaceum induced by NAD+/NADH+ imbalance

Discovery of antibacterial biotin carboxylase inhibitors by virtual screening and fragment-based approaches

Profligate biotin synthesis in α-proteobacteria - a developing or degenerating regulatory system?

Expression and characterization of pantothenate energy‐coupling factor transporters as an anti‐infective drug target

Phenomenological interpretations of the mechanism for the concentration-dependent positive effect of antibiotic lincomycin on Streptomyces coelicolor A3(2)

Metabolic labeling-mediated visualization, capture, and inactivation of Gram-positive bacteria via biotin–streptavidin interactions